Person: Noubar Afeyan
Asia Leaders
Noubar Afeyan Is Exporting Flagship’s Venture Factory to Sovereign Health Systems
Flagship Pioneering is extending its venture-creation model through Saudi, Singaporean and British institutions. Noubar Afeyan must convert privileged data and regulatory access into investable companies without compromising privacy, ownership or speed.
Asia Leaders
Noubar Afeyan Oversaw Moderna’s $2.2 Billion Cost Reset. The Cash Runway Is the Board’s Next Test
Noubar Afeyan’s most consequential job in 2026 is chairing Moderna through a costly transition. The board has backed deep savings and a tighter pipeline; its next obligation is to show that lower spending can produce durable medicines before cash declines too far.